HEADER HYDROLASE 20-DEC-19 6TS6 TITLE COAGULATION FACTOR XI PROTEASE DOMAIN IN COMPLEX WITH ACTIVE SITE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR XI; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FXI,PLASMA THROMBOPLASTIN ANTECEDENT,PTA; COMPND 5 EC: 3.4.21.27; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: F11; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS S1 PROTEASE, SERINE PROTEASE, STRUCTURE-BASED DRUG DESIGN, ACTIVE KEYWDS 2 SITE DIRECTED INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.RENATUS,N.SCHIERING REVDAT 3 13-NOV-24 6TS6 1 REMARK REVDAT 2 26-AUG-20 6TS6 1 JRNL REVDAT 1 08-JUL-20 6TS6 0 JRNL AUTH E.LORTHIOIS,J.ROACHE,D.BARNES-SEEMAN,E.ALTMANN,U.HASSIEPEN, JRNL AUTH 2 G.TURNER,R.DUVADIE,V.HORNAK,R.G.KARKI,N.SCHIERING, JRNL AUTH 3 W.A.WEIHOFEN,F.PERRUCCIO,A.CALHOUN,T.FAZAL,D.DEDIC,C.DURAND, JRNL AUTH 4 S.DUSSAUGE,K.FETTIS,F.TRITSCH,C.DENTEL,A.DRUET,D.LIU, JRNL AUTH 5 L.KIRMAN,J.LACHAL,K.NAMOTO,D.BEVAN,R.MO,G.MONNET,L.MULLER, JRNL AUTH 6 R.ZESSIS,X.HUANG,L.LINDSLEY,T.CURRIE,Y.H.CHIU,C.FRIDRICH, JRNL AUTH 7 P.DELGADO,S.WANG,M.HOLLIS-SYMYNKYWICZ,J.BERGHAUSEN, JRNL AUTH 8 E.WILLIAMS,H.LIU,G.LIANG,H.KIM,P.HOFFMANN,A.HEIN,P.RAMAGE, JRNL AUTH 9 A.D'ARCY,S.HARLFINGER,M.RENATUS,S.RUEDISSER,D.FELDMAN, JRNL AUTH10 J.ELLIOTT,R.SEDRANI,J.MAIBAUM,C.M.ADAMS JRNL TITL STRUCTURE-BASED DESIGN AND PRECLINICAL CHARACTERIZATION OF JRNL TITL 2 SELECTIVE AND ORALLY BIOAVAILABLE FACTOR XIA INHIBITORS: JRNL TITL 3 DEMONSTRATING THE POWER OF AN INTEGRATED S1 PROTEASE FAMILY JRNL TITL 4 APPROACH. JRNL REF J.MED.CHEM. V. 63 8088 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32551603 JRNL DOI 10.1021/ACS.JMEDCHEM.0C00279 REMARK 2 REMARK 2 RESOLUTION. 1.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 55874 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2701 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.33 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.36 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.23 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2022 REMARK 3 BIN FREE R VALUE : 0.2154 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 56 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1875 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 224 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.66 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.86610 REMARK 3 B22 (A**2) : -4.63230 REMARK 3 B33 (A**2) : 2.76620 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.170 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.058 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.058 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.056 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.056 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.925 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2030 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2766 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 701 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 342 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2030 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 258 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2016 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.54 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 13.77 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 24.7396 -2.2266 -3.5682 REMARK 3 T TENSOR REMARK 3 T11: -0.0268 T22: -0.0402 REMARK 3 T33: -0.0312 T12: -0.004 REMARK 3 T13: 0.009 T23: 0.0044 REMARK 3 L TENSOR REMARK 3 L11: 0.6841 L22: 0.693 REMARK 3 L33: 0.48 L12: -0.3294 REMARK 3 L13: 0.0342 L23: 0.0078 REMARK 3 S TENSOR REMARK 3 S11: 0.0009 S12: 0.0089 S13: -0.0442 REMARK 3 S21: 0.0089 S22: 0.021 S23: 0.0272 REMARK 3 S31: -0.0442 S32: 0.0272 S33: -0.0219 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6TS6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-DEC-19. REMARK 100 THE DEPOSITION ID IS D_1292105984. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000040 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : XSCALE JANUARY 30, 2009 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55884 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.330 REMARK 200 RESOLUTION RANGE LOW (A) : 60.070 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 4.883 REMARK 200 R MERGE (I) : 0.13400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.0900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.33 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.74 REMARK 200 R MERGE FOR SHELL (I) : 0.48500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.090 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULFATE, 0.1 M BIS-TRIS REMARK 280 PH5.5, 25% W/V POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.03000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 33.29500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.36500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 33.29500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.03000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.36500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 244 REMARK 465 VAL A 245 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 95 -60.86 -128.53 REMARK 500 SER A 214 -61.73 -127.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NW5 A 307 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6TS4 RELATED DB: PDB REMARK 900 RELATED ID: 6TS5 RELATED DB: PDB REMARK 900 RELATED ID: 6T7P RELATED DB: PDB DBREF 6TS6 A 16 245 UNP P03951 FA11_HUMAN 388 625 SEQADV 6TS6 SER A 123 UNP P03951 CYS 500 ENGINEERED MUTATION SEQRES 1 A 238 ILE VAL GLY GLY THR ALA SER VAL ARG GLY GLU TRP PRO SEQRES 2 A 238 TRP GLN VAL THR LEU HIS THR THR SER PRO THR GLN ARG SEQRES 3 A 238 HIS LEU CYS GLY GLY SER ILE ILE GLY ASN GLN TRP ILE SEQRES 4 A 238 LEU THR ALA ALA HIS CYS PHE TYR GLY VAL GLU SER PRO SEQRES 5 A 238 LYS ILE LEU ARG VAL TYR SER GLY ILE LEU ASN GLN SER SEQRES 6 A 238 GLU ILE LYS GLU ASP THR SER PHE PHE GLY VAL GLN GLU SEQRES 7 A 238 ILE ILE ILE HIS ASP GLN TYR LYS MET ALA GLU SER GLY SEQRES 8 A 238 TYR ASP ILE ALA LEU LEU LYS LEU GLU THR THR VAL ASN SEQRES 9 A 238 TYR THR ASP SER GLN ARG PRO ILE SER LEU PRO SER LYS SEQRES 10 A 238 GLY ASP ARG ASN VAL ILE TYR THR ASP CYS TRP VAL THR SEQRES 11 A 238 GLY TRP GLY TYR ARG LYS LEU ARG ASP LYS ILE GLN ASN SEQRES 12 A 238 THR LEU GLN LYS ALA LYS ILE PRO LEU VAL THR ASN GLU SEQRES 13 A 238 GLU CYS GLN LYS ARG TYR ARG GLY HIS LYS ILE THR HIS SEQRES 14 A 238 LYS MET ILE CYS ALA GLY TYR ARG GLU GLY GLY LYS ASP SEQRES 15 A 238 ALA CYS LYS GLY ASP SER GLY GLY PRO LEU SER CYS LYS SEQRES 16 A 238 HIS ASN GLU VAL TRP HIS LEU VAL GLY ILE THR SER TRP SEQRES 17 A 238 GLY GLU GLY CYS ALA GLN ARG GLU ARG PRO GLY VAL TYR SEQRES 18 A 238 THR ASN VAL VAL GLU TYR VAL ASP TRP ILE LEU GLU LYS SEQRES 19 A 238 THR GLN ALA VAL HET SO4 A 301 5 HET SO4 A 302 5 HET SO4 A 303 5 HET DMS A 304 4 HET DMS A 305 4 HET DMS A 306 4 HET NW5 A 307 33 HETNAM SO4 SULFATE ION HETNAM DMS DIMETHYL SULFOXIDE HETNAM NW5 2-[2-[[3-[(3~{S})-3-AZANYL-2,3-DIHYDRO-1-BENZOFURAN-5- HETNAM 2 NW5 YL]-5-(2-CYANOPROPAN-2-YL) HETNAM 3 NW5 PHENYL]METHOXY]PHENYL]ETHANOIC ACID FORMUL 2 SO4 3(O4 S 2-) FORMUL 5 DMS 3(C2 H6 O S) FORMUL 8 NW5 C27 H26 N2 O4 FORMUL 9 HOH *224(H2 O) HELIX 1 AA1 ALA A 55 TYR A 59A 5 6 HELIX 2 AA2 SER A 61 LYS A 63 5 3 HELIX 3 AA3 ASN A 73 ILE A 77 5 5 HELIX 4 AA4 MET A 96 GLY A 100 5 5 HELIX 5 AA5 THR A 164 TYR A 172 1 9 HELIX 6 AA6 TYR A 234 GLN A 243 1 10 SHEET 1 AA1 8 THR A 20 ALA A 21 0 SHEET 2 AA1 8 GLN A 156 LYS A 159 -1 O LYS A 157 N THR A 20 SHEET 3 AA1 8 CYS A 136 GLY A 140 -1 N VAL A 138 O ALA A 158 SHEET 4 AA1 8 PRO A 198 HIS A 202A-1 O SER A 198B N TRP A 137 SHEET 5 AA1 8 VAL A 202D TRP A 215 -1 O VAL A 202D N HIS A 202A SHEET 6 AA1 8 GLY A 226 ASN A 230 -1 O VAL A 227 N TRP A 215 SHEET 7 AA1 8 MET A 180 ALA A 183 -1 N ILE A 181 O TYR A 228 SHEET 8 AA1 8 LEU A 162 VAL A 163 -1 N VAL A 163 O CYS A 182 SHEET 1 AA2 7 GLN A 30 THR A 35 0 SHEET 2 AA2 7 ARG A 37D GLY A 46 -1 O LEU A 39 N LEU A 33 SHEET 3 AA2 7 TRP A 51 THR A 54 -1 O LEU A 53 N SER A 43 SHEET 4 AA2 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 5 AA2 7 PHE A 83 ILE A 90 -1 N ILE A 89 O LEU A 105 SHEET 6 AA2 7 LEU A 65 TYR A 68 -1 N VAL A 67 O PHE A 83 SHEET 7 AA2 7 GLN A 30 THR A 35 -1 N HIS A 34 O ARG A 66 SSBOND 1 CYS A 40 CYS A 58 1555 1555 2.04 SSBOND 2 CYS A 136 CYS A 201 1555 1555 2.06 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.02 SSBOND 4 CYS A 191 CYS A 219 1555 1555 2.06 CISPEP 1 SER A 37 PRO A 37A 0 3.77 SITE 1 AC1 6 THR A 177 HIS A 178 HOH A 420 HOH A 446 SITE 2 AC1 6 HOH A 466 HOH A 517 SITE 1 AC2 9 GLN A 93 TYR A 101 ASP A 135 TRP A 137 SITE 2 AC2 9 LYS A 179 LYS A 202 HOH A 401 HOH A 406 SITE 3 AC2 9 HOH A 586 SITE 1 AC3 7 LYS A 127 GLY A 128 ASP A 129 ARG A 130 SITE 2 AC3 7 HOH A 435 HOH A 464 HOH A 469 SITE 1 AC4 6 TYR A 133 LEU A 162 ILE A 181 ASN A 230 SITE 2 AC4 6 HOH A 418 HOH A 485 SITE 1 AC5 4 HIS A 202A ASN A 202B HOH A 505 HOH A 549 SITE 1 AC6 5 THR A 164 ASN A 165 GLU A 166 HIS A 178 SITE 2 AC6 5 HOH A 522 SITE 1 AC7 15 HIS A 57 ASP A 189 ALA A 190 CYS A 191 SITE 2 AC7 15 LYS A 192 GLY A 193 ASP A 194 SER A 195 SITE 3 AC7 15 THR A 213 TRP A 215 GLY A 216 GLY A 218 SITE 4 AC7 15 CYS A 219 HOH A 571 HOH A 572 CRYST1 60.060 60.730 66.590 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016650 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016466 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015017 0.00000